PT-141email:jaymee at ycphar dot com. skype:jaymee_49Product Name: PT-141Synonyms: BREMELANOTIDE;Brmelanotice;Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH;Bremelanotide, PT141,PT-141;BREMELANOTIDE PT141;N-Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine (2-7)-lactam;PT141 Acetate,BreMelanotide AcetateCAS: 189691-06-3MF: C50H68N14O10MW: 1025.18use:Female Sexual DysfunctionPacking:Foil bag or as requirmentsmore details:PT-141 is Palatin Technologies Co., Ltd. developed an expectation for the treatment of sexual dysfunction peptide drugs. For studies suggest, PT-141 is by stimulating the central nervous system and produces a black glucocorticoid receptor therapeutically active, existing drugs which act directly on the vasculature is entirely different. Preclinical studies in animal models found that administration of PT-141 allows the female animal requirements are dramatically improved, which is the fundamental cause Palatin Technologies Co. I trial of the above reasons. PT-141 is also developed as men with erectile dysfunction drugs. Two days before (September 24), international and Impotence Research Society annual meeting Palatin Technologies Co., Ltd. has just held in Montreal, Canada, announced the positive results of PT-141 for the treatment of male sexual dysfunction IIa clinical trials available. Palatin Technologies Co., Ltd. plans to begin this fall, evaluate PT-141 administered at home treatment of men with erectile dysfunction IIb research.
Hilfe
Zu Favoriten 
Dem Warenkorb hinzugefügte Favoriten
